Patents by Inventor Jose Pablo BERTRAND NAVARRETE

Jose Pablo BERTRAND NAVARRETE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of IL-3, IL-33 and IL-12p40 as markers for characterization of respiratory infections by respiratory syncytial virus
    Patent number: 11085080
    Abstract: The present invention is related to detecting respiratory diseases using molecular markers as prognostic tool of the evolution of respiratory infection cases. Concretely, during the differential diagnostic of respiratory infections caused by the Syncytial Respiratory Virus and human Metapneumovirus, it will be established the expression pattern of the severity markers of IL-3, IL-33 and IL12p40. The expression pattern of the molecular markers can be defined in biological samplers using ELISA assays, flow cytometry or PCR in real time. The confirmation of the etiological agent of the infection in combination to the pattern definition of the molecular markers IL-3, IL-33 and IL12p40 will indicate a prognostic of the disease severity.
    Type: Grant
    Filed: July 25, 2016
    Date of Patent: August 10, 2021
    Assignee: PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
    Inventors: Alexis Mikes Kalergis Parra, Susan Marcela Bueno Ramirez, Jose Pablo Bertrand Navarrete, Margarita Kam-Lem Lay Remolcoi
  • USE OF IL-3, IL-33, AND IL-12p40 FOR CHARACTERIZATION OF THE RESPIRATORY INFECTIONS BY SYNCYTIAL RESPIRATORY VIRUS
    Publication number: 20180327843
    Abstract: The present invention is related to detecting respiratory diseases using molecular markers as prognostic tool of the evolution of respiratory infection cases. Concretely, during the differential diagnostic of respiratory infections caused by the Syncytial Respiratory Virus and human Metapneumovirus, it will be established the expression pattern of the severity markers of IL-3, IL-33 and IL12p40. The expression pattern of the molecular markers can be defined in biological samplers using ELISA assays, flow cytometry or PCR in real time. The confirmation of the etiological agent of the infection in combination to the pattern definition of the molecular markers IL-3, IL-33 and IL12p40 will indicate a prognostic of the disease severity.
    Type: Application
    Filed: July 25, 2016
    Publication date: November 15, 2018
    Inventors: Alexis Mikes KALERGIS PARRA, Susan Marcela BUENO RAMIREZ, Jose Pablo BERTRAND NAVARRETE, Margarita Kam-Lem LAY REMOLCOI